Evidence map›Paper›PMID 37771132›Full record

ArticlePediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society

The Incidence of Multiple Fusions in a Series of Pediatric Soft Tissue and Bone Tumors.

Anastasia MacKeracher, Anthony Arnoldo, Robert Siddaway, Lea F Surrey, Gino R Somers

Open access · hybridAbstract read
In one paragraph

Article in Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. TheFrontiers in oncology · 2026
    Article
  3. Article
  4. Beyond Hybrid Morphology: A Large Series of Fusion-Driven Benign Peripheral Nerve Sheath Tumors Including 5 Tumors With Novel Fusions.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anastasia MacKeracherDepartment of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Anthony ArnoldoDepartment of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.ORCID 0000-0003-0687-3040
Robert SiddawayDepartment of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.ORCID 0000-0003-2013-9467
Lea F SurreyDepartment of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.
Gino R SomersDepartment of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.ORCID 0000-0003-3830-7959
Hospital for Sick Children · CAChildren's Hospital of Philadelphia · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNext generation sequencing (NGS) has increased the detection of fusion genes in cancer. NGS has found multiple fusions in single tumor samples; however, the incidence of this in pediatric soft tissue and bone tumors (PSTBTs) is not well documented. The aim of this study is to catalogue the incidence of multiple fusions in a series of PSTBTs, and apply a modified gene fusion classification system to determine clinical relevance. METHODOLOGY: RNA from 78 bone and soft tissue tumors and 7 external quality assessment samples were sequenced and analyzed using recently-described Metafusion (MF) software and classified using a modification of previously-published schema for fusion classification into 3 tiers: 1, strong clinical significance; 2, potential clinical significance; and 3, unknown clinical significance.

resultsOne-hundred forty-five fusions were detected in 85 samples. Fifty-five samples (65%) had a single fusion and 30 (35%) had more than 1 fusion. No samples contained more than 1 tier 1 fusion. There were 40 tier 1 (28%), 36 tier 2 (24%), and 69 (48%) tier 3 fusions.

conclusionsA significant percentage of PSTBTs harbor more than 1 fusion, and by applying a modified fusion classification scheme, the potential clinical relevance of such fusions can be determined.

Indexed as

Bone NeoplasmsSoft Tissue NeoplasmsBase SequenceChildGene FusionHigh-Throughput Nucleotide SequencingHumansIncidenceOncogene Proteins, FusionOncogene Proteins, Fusionbone tumorsfusion classificationfusion genesfusion pathogenicitymolecular oncologysoft tissue tumors

Identifiers

PMID37771132
PMCPMC10800079
OpenAlexW4387157768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.